nach oben

AIDS and Behavior

Erschienen in:

19.12.2016 | Original Paper

HIV Disclosure and Unprotected Sex Among Vietnamese Men with a History of Drug Use

verfasst von: Li Li, Sitong Luo, Benjamin Rogers, Sung-Jae Lee, Nguyen Anh Tuan

Erschienen in: AIDS and Behavior | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Additional barriers to self-disclosure of HIV status exist for people living with HIV (PLH) with a history of drug use. The objectives of this study were to explore the extent of HIV disclosure, sexual practice patterns and the relationships between HIV disclosure and unprotected sex among Vietnamese male PLH with a history of drug use. We used cross-sectional data of a sample of 133 PLH collected from a randomized controlled intervention trial in Vietnam. More than one-quarter of the participants reported not disclosing their HIV status to any sexual partners. Self-reported rates of condom use were 67.8, 51.1 and 32.6% with regular, casual, and commercial partners, respectively. Unprotected sex, testing positive for heroin, and fewer years since HIV diagnosis were significantly associated with lower level of HIV disclosure. Future intervention programs should focus on the complex interplay among HIV disclosure, drug use, and unprotected sexual practices in this vulnerable population.

Hays RB, McKusick L, Pollack L, Hilliard R, Hoff C, Coates TJ. Disclosing HIV seropositivity to significant others. AIDS. 1993;7(3):425–32.CrossRefPubMed

Kalichman SC, Kalichman MO, Cherry C, Grebler T. HIV disclosure and transmission risks to sex partners among HIV-positive men. AIDS Patient Care STDs. 2016;30(5):221–8.CrossRefPubMedPubMedCentral

Ding Y, Li L, Ji G. HIV disclosure in rural China: predictors and relationship to access to care. AIDS Care. 2011;23(9):1059–66.CrossRefPubMedPubMedCentral

Smith R, Rossetto K, Peterson BL. A meta-analysis of disclosure of one’s HIV-positive status, stigma and social support. AIDS Care. 2008;20(10):1266–75.CrossRefPubMed

Zang C, He X, Liu H. Selective disclosure of HIV status in egocentric support networks of people living with HIV/AIDS. AIDS Behav. 2015;19(1):72–80.CrossRefPubMedPubMedCentral

Brooks RA, Kaplan RL, Lieber E, Landovitz RJ, Lee SJ, Leibowitz AA. Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care. 2011;23(9):1136–45.CrossRefPubMedPubMedCentral

Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRefPubMedPubMedCentral

Do NT, Phiri K, Bussmann H, Gaolathe T, Marlink RG, Wester CW. Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS Res Hum Retroviruses. 2010;26(6):685–91.CrossRefPubMedPubMedCentral

Przybyla SM, Golin CE, Widman L, Grodensky CA, Earp JA, Suchindran C. Serostatus disclosure to sexual partners among people living with HIV: examining the roles of partner characteristics and stigma. AIDS Care. 2013;25(5):566–72.CrossRefPubMed

10.

Serovich JM. A test of two HIV disclosure theories. AIDS Educ Preven. 2001;13(4):355.CrossRef

11.

Vyavaharkar M, Moneyham L, Corwin S, Tavakoli A, Saunders R, Annang L. HIV-disclosure, social support, and depression among HIV-infected African American women living in the rural southeastern United States. AIDS Educ Prev. 2011;23(1):78.CrossRefPubMed

12.

Go VF, Latkin C, Le Minh N, et al. Variations in the role of social support on disclosure among newly diagnosed HIV-infected people who inject drugs in Vietnam. AIDS Behav. 2016;20(1):155–64.CrossRefPubMedPubMedCentral

13.

Parsons JT, VanOra J, Missildine W, Purcell DW, Gómez CA. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Educ Prev. 2004;16(5):459.CrossRefPubMed

14.

Latkin CA, Knowlton AR, Forman VL, et al. Injection drug users’ disclosure of HIV seropositive status to network members. AIDS Behav. 2001;5(4):297–305.CrossRef

15.

Zhang C, Li X, Liu Y, et al. Stigma against people living with HIV/AIDS in China: does the route of infection matter? PLoS ONE. 2016;11(3):e0151078.CrossRefPubMedPubMedCentral

16.

Valle M, Levy J. Weighing the consequences self-disclosure of HIV-positive status among African American injection drug users. Health Educ Behav. 2009;36(1):155–66.CrossRefPubMed

17.

Rudolph AE, Davis WW, Quan VM, et al. Perceptions of community-and family-level injection drug user (IDU)-and HIV-related stigma, disclosure decisions and experiences with layered stigma among HIV-positive IDUs in Vietnam. AIDS Care. 2012;24(2):239–44.PubMed

18.

Li L, Sun S, Wu Z, Wu S, Lin C, Yan Z. Disclosure of HIV status is a family matter: field notes from China. J Fam Psychol. 2007;21(2):307.CrossRefPubMedPubMedCentral

19.

Kalichman SC, DiMarco M, Austin J, Luke W, DiFonzo K. Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. J Behav Med. 2003;26(4):315–32.CrossRefPubMed

20.

Vu L, Andrinopoulos K, Mathews C, Chopra M, Kendall C, Eisele TP. Disclosure of HIV status to sex partners among HIV-infected men and women in Cape Town, South Africa. AIDS Behav. 2012;16(1):132–8.CrossRefPubMed

21.

Parsons JT, Missildine W, Van Ora J, Purcell DW, Gómez CA. HIV serostatus disclosure to sexual partners among HIV-positive injection drug users. AIDS Patient Care STDs. 2004;18(8):457–69.CrossRefPubMed

22.

Simoni JM, Pantalone DW. Secrets and safety in the age of AIDS: does HIV disclosure lead to safer sex? Top HIV Med. 2004;12:109–18.PubMed

23.

Holt R, Court P, Vedhara K, Nott KH, Holmes J, Snow MH. The role of disclosure in coping with HIV infection. AIDS Care. 1998;10(1):49–60.CrossRefPubMed

24.

Pinkerton SD, Galletly CL. Reducing HIV transmission risk by increasing serostatus disclosure: a mathematical modeling analysis. AIDS Behav. 2007;11(5):698–705.CrossRefPubMed

25.

National committee for AIDS, drug and prostitution prevention and control. Vietnam AIDS response progress report 2014. http://www.unaids.org/sites/default/files/en/dataanalysis/knowyourresponse/countryprogressreports/2014countries/VNM_narrative_report_2014.pdf. Accessed 14 July 2016.

26.

World Health Organization. Good practice in Asia: targeted HIV prevention for injecting drug users and sex workers. 2010. www.who.int/hiv/pub/idu/good_practice_aisa_idu.pdf. Accessed 14 July 2016.

27.

Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc. 1996;91(434):473–89.CrossRef

28.

King R, Katuntu D, Lifshay J, et al. Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda. AIDS Behav. 2008;12(2):232–43.CrossRefPubMed

29.

Go VF, Frangakis C, Le Minh N, et al. Efficacy of a multi-level intervention to reduce injecting and sexual risk behaviors among HIV-infected people who inject drugs in Vietnam: a four-arm randomized controlled trial. PLoS ONE. 2015;10(5):e0125909.CrossRefPubMedPubMedCentral

30.

Spiller MW, Broz D, Wejnert C, Nerlander L, Paz-Bailey G. HIV infection and HIV-associated behaviors among persons who inject drugs–20 cities, United States, 2012. MMWR Morb Mortal Wkly Rep. 2015;64(10):270–5.PubMed

31.

Meader N, Semaan S, Halton M, et al. An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav. 2013;17(6):1963–78.CrossRefPubMed

Titel: HIV Disclosure and Unprotected Sex Among Vietnamese Men with a History of Drug Use
verfasst von: Li Li
Sitong Luo
Benjamin Rogers
Sung-Jae Lee
Nguyen Anh Tuan
Publikationsdatum: 19.12.2016
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 9/2017
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-016-1648-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2017

Assessing the Impact of Perinatal HIV Case Management on Outcomes Along the HIV Care Continuum for Pregnant and Postpartum Women Living With HIV, Philadelphia 2005–2013

Gender, HIV Testing and Stigma: The Association of HIV Testing Behaviors and Community-Level and Individual-Level Stigma in Rural South Africa Differ for Men and Women

Drug use Discrimination Predicts Formation of High-Risk Social Networks: Examining Social Pathways of Discrimination

School, Supervision and Adolescent-Sensitive Clinic Care: Combination Social Protection and Reduced Unprotected Sex Among HIV-Positive Adolescents in South Africa

HIV Stigma and Substance Use Among HIV-Positive Russians with Risky Drinking

Effectiveness of a Brief Multi-Component Intervention to HIV Prevention Among Spanish Youth